Subscribe to our newsletter and receive the latest ion channel and receptor drug discovery insights straight to your email inbox!
subscribe today
Continue ReadingSB Drug Discovery are proud to announce our chosen charity partner for 2024 is Glasgow Children's Hospital Charity.
04 march 2024
Continue ReadingSB Drug Discovery are exhibiting at this year's annual BPS meeting at booth 527. SB Drug Discovery are also co-sponsoring the "Drug Discovery for Ion Channels XXIV" satellite meeting.
04 january 2024
Continue ReadingDiscover ground breaking neuroscience research at Neuroscience Conference 2023. Join SB Drug Discovery, Sygnature Discovery, and NuChem Sciences for a unified showcase at booths 930 and 932.
23 October 2023
Continue ReadingTaking a leap forward in transporter research with the acquisition of SURFE2R 96SE. Hear from our Scientific Director, Ian McPhee, on how this technology will elevate our research capabilities.
28 Septemer 2023
Continue Reading
Sygnature Discovery has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences.
1 AUgust 2023
Continue ReadingSB Drug Discovery is excited to announce it has been acquired by Sygnature Discovery to further enhance our market leading capabilities.
17 january 2023
Continue Reading